China Resources Medical Holdings Company Limited's (HKG:1515) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged HK$428m Last Week
China Resources Medical Holdings Company Limited's (HKG:1515) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged HK$428m Last Week
Key Insights
主要见解
- China Resources Medical Holdings' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
- The top 6 shareholders own 51% of the company
- Institutions own 21% of China Resources Medical Holdings
- 中国资源医疗控股的重要个人投资者持股情况表明,关键决策受到更大公众股东的影响
- 前6大股东拥有公司51%的股份。
- 机构拥有中国资源医疗控股21%的股权
Every investor in China Resources Medical Holdings Company Limited (HKG:1515) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 43% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
每位投资中国资源医疗控股有限公司(HKG:1515)的投资者都应该注意最强大的股东群体。持有公司43%股权的个人投资者群体占据着最大的股份。换句话说,该群体将从他们对公司的投资中获得最多(或损失最多)的回报。
Clearly, individual investors benefitted the most after the company's market cap rose by HK$428m last week.
显然,个人投资者在上周公司市值增加了42800万港元后受益最多。
Let's delve deeper into each type of owner of China Resources Medical Holdings, beginning with the chart below.
让我们深入研究中国资源医疗控股的每种所有者类型,从下面的图表开始。
What Does The Institutional Ownership Tell Us About China Resources Medical Holdings?
机构持股告诉我们有关中国资源医疗控股的什么?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
机构通常在向自己的投资者报告时会针对一个基准进行衡量,因此一旦某只股票被纳入主要指数,他们通常会更加热衷于该股票。我们预计大多数公司都会有一些机构在登记簿上,尤其是那些正在增长的公司。
As you can see, institutional investors have a fair amount of stake in China Resources Medical Holdings. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of China Resources Medical Holdings, (below). Of course, keep in mind that there are other factors to consider, too.
正如您所看到的,机构投资者在中国资源医疗控股中持有相当大比例的股份。 这表明在专业投资者中有一定的可信度。 但我们不能仅依靠这个事实,因为机构有时也会做出糟糕的投资,就像每个人一样。 如果两家大型机构投资者同时试图抛售某只股票,很可能会看到股价大幅下跌。 因此,值得检查中国资源医疗控股的过往盈利轨迹(如下)。 当然,也要记住还有其他因素需要考虑。
Hedge funds don't have many shares in China Resources Medical Holdings. Our data shows that China Resources Company Limited is the largest shareholder with 37% of shares outstanding. For context, the second largest shareholder holds about 4.9% of the shares outstanding, followed by an ownership of 3.4% by the third-largest shareholder.
对于华润医疗控股,对冲基金持有的股份不多。我们的数据显示,中国华润有限公司是最大的股东,持有37%的流通股份。第二大股东持有约4.9%的流通股份,而第三大股东持有3.4%的流通股份。
We did some more digging and found that 6 of the top shareholders account for roughly 51% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.
我们进行了更深入的研究,发现前6名股东大约占有51%的持股比例,意味着除了大股东以外,还有一些小股东,因此在一定程度上平衡了各自的利益。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.
尽管研究公司机构所有权数据是有意义的,但了解分析师的情绪也很有意义,以了解市场的走向。因为有很多分析师正在跟踪这个股票,所以看看他们的预测可能是值得的。
Insider Ownership Of China Resources Medical Holdings
华润医疗控股的内部所有权
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
内部人员的定义在不同国家可能会稍有不同,但董事会成员始终算入其中。公司管理负责经营业务,但即使首席执行官是董事会成员,他或她也必须对董事会负责。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常认为内部人士持股是一件好事。但是,在某些情况下,它会使其他股东更难以对董事会的决定进行问责。
Our data suggests that insiders own under 1% of China Resources Medical Holdings Company Limited in their own names. However, it's possible that insiders might have an indirect interest through a more complex structure. It has a market capitalization of just HK$4.9b, and the board has only HK$1.8m worth of shares in their own names. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.
我们的数据表明,内部人士以自己的名义拥有不到1%的华润医药控股有限公司股份。然而,内部人士可能通过更复杂的结构间接持有利益。其市值仅为HK$49亿,董事会仅以自己的名义持有HK$180万价值的股份。许多投资者在较小公司中更希望看到董事会投资更重。您可以点击这里查看这些内部人士是否一直在买入或卖出。
General Public Ownership
一般大众所有权
The general public-- including retail investors -- own 43% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
包括散户在内的普通公众拥有该公司43%的股份,因此不能轻易忽视他们。尽管所有权规模相当大,但如果决定与其他大股东不一致,这可能还不足以改变公司政策。
Private Company Ownership
私有公司的所有权
It seems that Private Companies own 37%, of the China Resources Medical Holdings stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
中国资源医疗控股股份有限公司的37%股份似乎由私营公司持有。值得进一步深入了解。如果相关方,如内部人员,在这些私营公司中有利害关系,这应在年度报告中披露。私营公司可能也对该公司具有战略利益。
Next Steps:
下一步:
While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 2 warning signs for China Resources Medical Holdings that you should be aware of before investing here.
虽然考虑拥有公司股份的不同群体很重要,但还有其他更重要的因素。例如,我们发现了中国资源医疗控股存在2个警告信号,您在投资之前应该了解这些。
If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.
如果您希望了解分析师在未来增长方面的预测,请务必不要错过这份免费报告。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。